Though not as large some thought they would be, the list prices for Kymriah and Yescarta still made them two of the most expensive treatments in the world. The way the therapies worked also poked holes in the drug pricing paradigm.

https://www.biopharmadive.com/news/medicare-to-pay-hundreds-of-thousands-for-car-t-therapies/520806/